Veeva Unveils eSource to Eliminate Paper at Clinical Research Sites

VEEV
January 30, 2026

Veeva Systems announced the launch of Veeva eSource, a new application within its SiteVault platform that captures clinical data directly at the site and streams it straight into the sponsor’s electronic data capture (EDC) system. The solution removes the need for paper case report forms and eliminates the manual data‑entry step that has long plagued clinical trials.

eSource integrates with SiteVault’s clinical trial management system (CTMS) and exposes an open API that allows any EDC vendor to pull data in real time. By capturing data in the source system, the product reduces transcription errors, shortens the data‑cleaning cycle, and frees site staff to focus on patient care rather than paperwork.

Early‑adopter sites will receive the new functionality in the second half of 2026, giving Veeva a first‑mover advantage in a market that still relies heavily on paper and fragmented data flows. The timing aligns with the company’s broader strategy to deliver a unified clinical platform that spans site, sponsor, and regulatory workflows.

The launch is expected to deepen customer lock‑in and open new revenue streams in the clinical data‑management segment. By solving a persistent pain point—paper‑based data capture—Veeva can capture a larger share of the data‑capture market, which is projected to grow as sponsors seek faster, more accurate trial timelines. The product also positions Veeva to compete more directly with emerging eSource vendors that offer similar functionality but lack the integrated SiteVault ecosystem.

Jim Reilly, President of Veeva Development Cloud, said the launch “connects data and processes to enable straight‑through clinical data flow from site to sponsor, a major step toward simplifying, standardizing, and connecting clinical trials.” Nick Frenzer, general manager of Veeva site solutions, added that eSource “advances our goal of delivering significant efficiency and simplicity for clinical trial sites, completing the picture for integrated data transparency.”

Industry analysts note that the life‑science sector still spends a significant portion of trial budgets on paper and manual data entry. By eliminating these steps, Veeva’s eSource addresses a key cost driver and can accelerate time to market for new therapies, potentially giving the company a competitive edge in a crowded clinical‑data‑management landscape.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.